Ramesh Jagadeesan, vice president, head of analytical services at Recipharm shares his insights on the role of analytical services in drug development.
CARBOGEN AMCIS Shanghai facility has successfully obtained its first Drug Manufacturing License (DML) from China’s National Medical Products Administration (NMPA).
Digital adoption platforms (a simple overlay to web/cloud-based systems) offer a practical solution, guiding users of each application, step by step, in correct, compliant data input. MAIN5’s Sabine Gölden assesses their potential.
Shilpa Medicare announces that Shilpa Pharma Lifesciences – a wholly owned subsidiary – has successfully passed a U.S. Food and Drug Administration (FDA) inspection for its Unit-2 facility in Raichur, India, with no 483 observations.
4basebio has announced that it has received Good Manufacturing Practice (GMP) certification from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA).
Bonfiglioli Engineering, a provider of advanced leak detection and packaging integrity solutions for the pharmaceutical industry, announces its participation at INTERPHEX 2025.
With increasing regulatory requirements and the need for full traceability, manufacturers are turning to advanced technologies like EyeVision Software to streamline quality control processes.
Antares Vision Group will offer live demonstrations of a high-speed system providing 100% inspection and leak detection for liquid-filled glass containers at INTERPHEX NYC, 1-3rd April in New York.
BGS US recently acquired quality certifications for ISO 13485 and ISO 9001, and the confirmation of ISO 11137 for its 100,000- square-foot Electron Beam (E-Beam) sterilisation facility in Imperial, PA. The facility will begin operations in mid-2025.
Global contract manufacturing organisation (CMO) Symbiosis Pharmaceutical Services has completed its latest inspection by the US Food and Drug Administration (FDA) of its facilities in Scotland.
